متابعة
Jianjun Zhang
Jianjun Zhang
Professor, Dept. Thoracic/Head and Neck Medical Oncology, Dept. Genomic Medicine, MD
بريد إلكتروني تم التحقق منه على mdanderson.org
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma‏
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...‏
Cancer discovery 8 (7), 822-835, 2018‏
13952018
Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional …‏
DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ...‏
Journal of Clinical Oncology 37 (18), 1558-1565, 2019‏
11622019
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic …‏
DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ...‏
The lancet oncology 17 (12), 1672-1682, 2016‏
11102016
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing‏
J Zhang, J Fujimoto, J Zhang, DC Wedge, X Song, J Zhang, S Seth, ...‏
Science 346 (6206), 256-259, 2014‏
10682014
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic …‏
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...‏
Cancer discovery 5 (8), 860-877, 2015‏
8602015
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial‏
T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ...‏
Nature medicine 27 (3), 504-514, 2021‏
5322021
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma‏
Y Zhou, D Yang, Q Yang, X Lv, W Huang, Z Zhou, Y Wang, Z Zhang, ...‏
Nature communications 11 (1), 6322, 2020‏
4012020
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC‏
X Le, S Puri, MV Negrao, MB Nilsson, J Robichaux, T Boyle, JK Hicks, ...‏
Clinical Cancer Research 24 (24), 6195-6203, 2018‏
3682018
Structure-based classification predicts drug response in EGFR-mutant NSCLC‏
JP Robichaux, X Le, RSK Vijayan, JK Hicks, S Heeke, YY Elamin, HY Lin, ...‏
Nature 597 (7878), 732-737, 2021‏
3292021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer‏
CA Stewart, CM Gay, Y Xi, S Sivajothi, V Sivakamasundari, J Fujimoto, ...‏
Nature cancer 1 (4), 423-436, 2020‏
3292020
MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data‏
Y Fan, L Xi, DST Hughes, J Zhang, J Zhang, PA Futreal, DA Wheeler, ...‏
Genome biology 17, 1-11, 2016‏
3082016
Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases‏
GM Fischer, A Jalali, DA Kircher, WC Lee, JL McQuade, LE Haydu, ...‏
Cancer discovery 9 (5), 628-645, 2019‏
2982019
Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status‏
B Ricciuti, KC Arbour, JJ Lin, A Vajdi, N Vokes, L Hong, J Zhang, ...‏
Journal of Thoracic Oncology 17 (3), 399-410, 2022‏
2732022
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer‏
G Schvartsman, SA Peng, G Bis, JJ Lee, MFK Benveniste, J Zhang, ...‏
Lung cancer 112, 90-95, 2017‏
2122017
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study.‏
T Cascone, WN William, A Weissferdt, HY Lin, CH Leung, BW Carter, ...‏
Journal of Clinical Oncology 37 (15_suppl), 8504-8504, 2019‏
2112019
Caspase-dependent and-independent activation of acid sphingomyelinase signaling‏
JA Rotolo, J Zhang, M Donepudi, H Lee, Z Fuks, R Kolesnick‏
Journal of Biological Chemistry 280 (28), 26425-26434, 2005‏
2112005
Comprehensive T cell repertoire characterization of non-small cell lung cancer‏
A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ...‏
Nature communications 11 (1), 603, 2020‏
2012020
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer‏
MV Negrao, F Skoulidis, M Montesion, K Schulze, I Bara, V Shen, H Xu, ...‏
Journal for immunotherapy of cancer 9 (8), 2021‏
1992021
TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence‏
A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ...‏
Cancer discovery 7 (10), 1088-1097, 2017‏
1952017
ATM regulates target switching to escalating doses of radiation in the intestines‏
HJ Ch'ang, JG Maj, F Paris, HR Xing, J Zhang, JP Truman, ...‏
Nature medicine 11 (5), 484-490, 2005‏
1722005
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20